Axplora operates nine API manufacturing sites across Europe and India, with the goal of providing multi-site capacity to ...
MaxCyte's technology will support TG Therapeutics' efforts to develop a CD19 CAR T cell therapy program for autoimmune diseases.
A bioprocessing research and training institute in Ireland has successfully tested two new techniques for noninvasive monitoring of cell viability.
In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...
XoZymes replaces traditional chemical production methods with an approach that integrates widely available feedstocks like sugar and biomass with advanced enzymes engineered to thrive outside living ...
Boehringer will leverage ExpressionEdits' Genetic Syntax Engine which generates optimized introns to increase protein expression.
Nanoneedle technology offers the capability to simultaneously quantify titers of true, full viral genomes and a range of partial species.
The versatility of biological products to treat disease never before considered has led numerous biopharmaceutical companies recently to announce expansions of production bioreactor capacity in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback